Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70
NCT02858999
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
PAD-VCD
Sponsor
Centre Hospitalier Universitaire, Amiens